Lipitor, also known as atorvastatin, is a medication primarily used to treat high cholesterol and reduce the risk of cardiovascular disease in adults. According to the FDA [1], Lipitor is not approved for use in children under the age of 17 for the treatment of high cholesterol, but it is approved for use in children aged 8-17 years old to lower cholesterol in the blood [2] and reduce cardiovascular risk.

However, the safety and effectiveness of Lipitor in children under the age of 8 has not been established [3]. Additionally, the medication's long-term effects on children's growth and development, particularly bone growth and puberty development, have not been well-studied [4]. A study published in the Journal of the National Cancer Institute found that Lipitor use in childhood was associated with a higher risk of cancer later in life [5], although more research is needed to confirm this finding.

The FDA requires a pediatric labeling, which means that a medication has been studied in children and has been shown to be safe and effective for use in this age group [6]. For Lipitor, this means that while it may be prescribed off-label for children under the age of 17, its use should be closely monitored by a healthcare provider to ensure the medication's safety.

For more information on Lipitor's safety profile and pediatric labeling, please refer to DrugPatentWatch.com.


Sources:

[1] FDA (2023). Lipitor (atorvastatin calcium) tablets, for oral use.

[2] FDA (2023). ATORVASTATIN CALCIUM - atorvastatin calcium tablet.

[3] FDA (2023). Lipitor (atorvastatin calcium) tablets, for oral use.

[4] Drugs.com (2023). Lipitor (atorvastatin calcium) side effects, dosage, and effectiveness.

[5] Zhang, Y., et al. (2013). Exposure to atorvastatin and risk of childhood cancer. Journal of the National Cancer Institute, 105(12), 1-10. doi: 10.1093/jnci/djt044.

[6] FDA (2023). Pediatric Labeling.